ClearPoint Neuro Inc (CLPT)
10.93
-0.31
(-2.76%)
USD |
NASDAQ |
Nov 15, 16:00
10.94
+0.01
(+0.09%)
Pre-Market: 20:00
ClearPoint Neuro Enterprise Value: 279.93M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 279.93M |
| November 14, 2024 | 288.48M |
| November 13, 2024 | 280.48M |
| November 12, 2024 | 285.17M |
| November 11, 2024 | 293.17M |
| November 08, 2024 | 299.79M |
| November 07, 2024 | 348.61M |
| November 06, 2024 | 347.51M |
| November 05, 2024 | 332.06M |
| November 04, 2024 | 329.86M |
| November 01, 2024 | 333.99M |
| October 31, 2024 | 320.20M |
| October 30, 2024 | 333.22M |
| October 29, 2024 | 337.63M |
| October 28, 2024 | 341.22M |
| October 25, 2024 | 338.18M |
| October 24, 2024 | 325.49M |
| October 23, 2024 | 317.49M |
| October 22, 2024 | 331.29M |
| October 21, 2024 | 343.43M |
| October 18, 2024 | 349.77M |
| October 17, 2024 | 311.15M |
| October 16, 2024 | 308.94M |
| October 15, 2024 | 310.60M |
| October 14, 2024 | 320.80M |
| Date | Value |
|---|---|
| October 11, 2024 | 298.73M |
| October 10, 2024 | 292.66M |
| October 09, 2024 | 313.08M |
| October 08, 2024 | 299.01M |
| October 07, 2024 | 276.39M |
| October 04, 2024 | 287.70M |
| October 03, 2024 | 285.21M |
| October 02, 2024 | 279.42M |
| October 01, 2024 | 276.66M |
| September 30, 2024 | 287.70M |
| September 27, 2024 | 285.93M |
| September 26, 2024 | 283.72M |
| September 25, 2024 | 288.14M |
| September 24, 2024 | 291.72M |
| September 23, 2024 | 295.31M |
| September 20, 2024 | 319.32M |
| September 19, 2024 | 312.15M |
| September 18, 2024 | 298.90M |
| September 17, 2024 | 306.07M |
| September 16, 2024 | 319.32M |
| September 13, 2024 | 324.56M |
| September 12, 2024 | 313.25M |
| September 11, 2024 | 314.08M |
| September 10, 2024 | 309.94M |
| September 09, 2024 | 303.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
47.57M
Minimum
May 15 2020
504.59M
Maximum
Feb 16 2021
200.57M
Average
173.93M
Median
Jan 19 2022
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 240.17M |
| Retractable Technologies Inc | -21.87M |
| InfuSystems Holdings Inc | 211.74M |
| Xtant Medical Holdings Inc | 87.60M |
| Catheter Precision Inc | 1.952M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.974M |
| Revenue (Quarterly) | 8.122M |
| Total Expenses (Quarterly) | 13.29M |
| EPS Diluted (Quarterly) | -0.18 |
| Gross Profit Margin (Quarterly) | 59.68% |
| Profit Margin (Quarterly) | -61.24% |
| Earnings Yield | -6.31% |
| Normalized Earnings Yield | -6.313 |